- TWD7.54bn
- TWD8.66bn
- TWD1.56bn
- 21
- 20
- 34
- 10
Annual income statement for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,869 | 1,794 | 2,252 | 1,785 | 1,557 |
| Cost of Revenue | |||||
| Gross Profit | 623 | 617 | 891 | 411 | 448 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,895 | 1,852 | 2,158 | 2,508 | 1,856 |
| Operating Profit | -25.8 | -58.5 | 93.6 | -723 | -299 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,197 | 14.3 | 156 | -770 | -336 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,197 | 14.3 | 146 | -770 | -336 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,241 | 43.1 | 291 | -640 | -243 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 1,241 | 43.1 | 291 | -640 | -243 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.03 | 0.11 | 0.68 | -1.52 | -0.576 |
| Dividends per Share |